(Q43215514)

16 November 2017

title

Rapid clearance of SAG-2 rabies virus from dogs after oral vaccination (English)

1 reference

16 November 2017

0 references

rabies virus

1 reference

inferred from title

author

Charles Edward Rupprecht

7

object named as

Rupprecht CE

1 reference

16 November 2017

Orciari LA

1

1 reference

16 November 2017

Niezgoda M

2

1 reference

16 November 2017

Hanlon CA

3

1 reference

16 November 2017

Shaddock JH

4

1 reference

16 November 2017

Sanderlin DW

5

1 reference

16 November 2017

Yager PA

6

1 reference

16 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

16 November 2017

1 reference

16 November 2017

volume

19

1 reference

16 November 2017

issue

31

1 reference

16 November 2017

page(s)

4511-4518

1 reference

Rationale and prospects for rabies elimination in developing countries.

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

Oral wildlife rabies vaccination field trials in Europe, with recent emphasis on France

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

Vaccination against rabies: construction and characterization of SAG2, a double avirulent derivative of SADBern

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

Evaluation of the safety of two attenuated oral rabies vaccines, SAG1 and SAG2, in six Arctic mammals.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

Safety study of the SAG2 rabies virus mutant in several non-target species with a view to its future use for the immunization of foxes in Europe.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

Innocuity studies of SAG-2 oral rabies vaccine in various Zimbabwean wild non-target species

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

Immunogenicity, efficacy and safety of an oral rabies vaccine (SAG-2) in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

Immunohistochemical test for rabies: identification of a diagnostically superior monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

Use of a single anti-nucleocapsid monoclonal antibody to detect rabies antigen in formalin-fixed, paraffin-embedded tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

Surveillance and epidemiologic mapping of monoclonal antibody-defined rabies variants in Florida.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

Unexplained rabies in three immigrants in the United States. A virologic investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

Epidemiologic and Historical Relationships among 87 Rabies Virus Isolates as Determined by Limited Sequence Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

Typing of rabies virus isolates by DNA enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

A comparison of two serological methods for detecting the immune response after rabies vaccination in dogs and cats being exported to rabies-free areas

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

The infectivity and pathogenesis of rabiesvirus administered orally

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

Oral vaccination of foxes against rabies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

The use of commercially available vaccines for the oral vaccination of foxes against rabies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

Consideration of inactivated rabies vaccines as oral immunogens of wild carnivores

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

Efficacy of a vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

Determination of the site of oral rabies vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

Oral vaccination of the fox against rabies using a live recombinant vaccinia virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

Immunobiology of lyssaviruses: the basis for immunoprotection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900186-4

7 January 2021

10.1016/S0264-410X(01)00186-4

Identifiers

DOI

1 reference

16 November 2017

1 reference